{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:05:50Z","timestamp":1769105150870,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"the Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["18K158951"],"award-info":[{"award-number":["18K158951"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00380-019-01513-y","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T23:49:02Z","timestamp":1569541742000},"page":"521-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function"],"prefix":"10.1007","volume":"35","author":[{"given":"Nobutaka","family":"Nagano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-3985","authenticated-orcid":false,"given":"Toshiyuki","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemichi","family":"Kouzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Muranaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Kishiue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"1513_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","volume":"4","author":"G Merlini","year":"2018","unstructured":"Merlini G, Dispenzieri A, Sanchorawala V, Sch\u00f6nland SO, Palladini G, Hawkins PN, Gertz MA (2018) Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers 4:38","journal-title":"Nat Rev Dis Primers"},{"key":"1513_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/bjh.13805","volume":"172","author":"E Kastritis","year":"2016","unstructured":"Kastritis E, Dimopoulos MA (2016) Recent advances in the management of AL amyloidosis. Br J Haematol 172:170\u2013186","journal-title":"Br J Haematol"},{"key":"1513_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","volume":"30","author":"S Kumar","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Colby C, Laumann K, Zeldenrust SR, Leung N, Dingli D, Greipp PR, Lust JA, Russell SJ, Kyle RA, Rajkumar SV, Gertz MA (2012) Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol 30:989\u2013995","journal-title":"J Clin Oncol"},{"key":"1513_CR4","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","volume":"68","author":"RH Falk","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Dorbala S (2016) AL (Light-Chain) cardiac amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol 68:1323\u20131341","journal-title":"J Am Coll Cardiol"},{"key":"1513_CR5","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1038\/leu.2014.227","volume":"28","author":"G Palladini","year":"2014","unstructured":"Palladini G, Milani P, Foli A, Vidus Rosin M, Basset M, Lavatelli F, Nuvolone M, Obici L, Perlini S, Merlini G (2014) Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients. Leukemia 28:2311\u20132316","journal-title":"Leukemia"},{"key":"1513_CR6","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1038\/leu.2014.218","volume":"28","author":"CP Venner","year":"2014","unstructured":"Venner CP, Gillmore JD, Sachchithanantham S, Mahmood S, Lane T, Foard D, Rannigan L, Gibbs SD, Pinney JH, Whelan CJ, Lachmann HJ, Hawkins PN, Wechalekar AD (2014) A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis. Leukemia 28:2304\u20132310","journal-title":"Leukemia"},{"key":"1513_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/ejh.12558","volume":"96","author":"ME Gatt","year":"2016","unstructured":"Gatt ME, Hardan I, Chubar E, Suriu C, Tadmor T, Shevetz O, Patachenco P, Dally N, Yeganeh S, Ballan-Haj M, Cohen Y, Trestman S, Muchtar E, Magen H, Jakubinsky J, Avivi I, Israeli MM study group (2016) Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessment. Eur J Haematol 96:136\u2013143","journal-title":"Eur J Haematol"},{"key":"1513_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1182\/blood-2015-01-620302","volume":"126","author":"G Palladini","year":"2015","unstructured":"Palladini G, Sachchithanantham S, Milani P, Gillmore J, Foli A, Lachmann H, Basset M, Hawkins P, Merlini G, Wechalekar AD (2015) A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis. Blood 126:612\u2013615","journal-title":"Blood"},{"key":"1513_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijcard.2018.05.018","volume":"271","author":"A Aimo","year":"2018","unstructured":"Aimo A, Buda G, Fontana M, Barison A, Vergaro G, Emdin M, Merlini G (2018) Therapies for cardiac light chain amyloidosis: an update. Int J Cardiol 271:152\u2013160","journal-title":"Int J Cardiol"},{"key":"1513_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis, Tours, France, 18\u201322 April 2004. Am J Hematol 79:319\u2013328","journal-title":"Am J Hematol"},{"key":"1513_CR11","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.2169\/internalmedicine.54.3500","volume":"54","author":"S Yuda","year":"2015","unstructured":"Yuda S, Hayashi T, Yasui K, Muranaka A, Ohnishi H, Hashimoto A, Ishida T, Tsuchihashi K, Shinomura Y, Watanabe N, Miura T (2015) Pericardial effusion and multiple organ involvement are independent predictors of mortality in patients with systemic light chain amyloidosis. Intern Med 54:1833\u20131840","journal-title":"Intern Med"},{"key":"1513_CR12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography (2005) Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 18:1440\u20131463","journal-title":"J Am Soc Echocardiogr"},{"key":"1513_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American society of echocardiography endorsed by the European association of echocardiography, a registered branch of the European society of cardiology, and the Canadian society of echocardiography. J Am Soc Echocardiogr 23:685\u2013713","journal-title":"J Am Soc Echocardiogr"},{"key":"1513_CR14","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/01.CIR.102.15.1788","volume":"102","author":"SR Ommen","year":"2000","unstructured":"Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788\u20131794","journal-title":"Circulation"},{"key":"1513_CR15","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1067\/mje.2002.124877","volume":"15","author":"H Yamada","year":"2002","unstructured":"Yamada H, Goh PP, Sun JP, Odabashian J, Garcia MJ, Thomas JD, Klein AL (2002) Prevalence of left ventricular diastolic dysfunction by Doppler echocardiography: clinical application of the Canadian consensus guidelines. J Am Soc Echocardiogr 15:1238\u20131244","journal-title":"J Am Soc Echocardiogr"},{"key":"1513_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jama.289.2.194","volume":"289","author":"MM Redfield","year":"2003","unstructured":"Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194\u2013202","journal-title":"JAMA"},{"key":"1513_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ejheart.2007.03.001","volume":"9","author":"J Kjaergaard","year":"2007","unstructured":"Kjaergaard J, Akkan D, Iversen KK, K\u00f8ber L, Torp-Pedersen C, Hassager C (2007) Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure. Eur J Heart Fail 9:610\u2013616","journal-title":"Eur J Heart Fail"},{"key":"1513_CR18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1053\/euhj.2000.2296","volume":"22","author":"J Meluz\u00edn","year":"2001","unstructured":"Meluz\u00edn J, Spinarov\u00e1 L, Bakala J, Toman J, Krejc\u00ed J, Hude P, K\u00e1ra T, Soucek M (2001) Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion; a new, rapid, and non-invasive method of evaluating right ventricular systolic function. Eur Heart J 22:340\u2013348","journal-title":"Eur Heart J"},{"key":"1513_CR19","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/echo.13220","volume":"33","author":"M Tadic","year":"2016","unstructured":"Tadic M, Cuspidi C, Kocijancic V, Celic V, Vukomanovic V (2016) Does left ventricular geometric patterns impact right atrial phasic function? Findings from the hypertensive population. Echocardiography 33:1186\u20131194","journal-title":"Echocardiography"},{"key":"1513_CR20","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1016\/j.jacc.2016.03.593","volume":"67","author":"BW Sperry","year":"2016","unstructured":"Sperry BW, Ikram A, Hachamovitch R, Valent J, Vranian MN, Phelan D, Hanna M (2016) Efficacy of chemotherapy for light-chain amyloidosis in patients presenting with symptomatic heart failure. J Am Coll Cardiol 67:2941\u20132948","journal-title":"J Am Coll Cardiol"},{"key":"1513_CR21","doi-asserted-by":"publisher","first-page":"e000881","DOI":"10.1136\/openhrt-2018-000881","volume":"5","author":"AM Agha","year":"2018","unstructured":"Agha AM, Parwani P, Guha A, Durand JB, Iliescu CA, Hassan S, Palaskas NL, Gladish G, Kim PY, Lopez-Mattei J (2018) Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart 5:e000881","journal-title":"Open Heart"},{"key":"1513_CR22","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jacc.2012.04.043","volume":"60","author":"SJ Buss","year":"2012","unstructured":"Buss SJ, Emami M, Mereles D, Korosoglou G, Kristen AV, Voss A, Schellberg D, Zugck C, Galuschky C, Giannitsis E, Hegenbart U, Ho AD, Katus HA, Schonland SO, Hardt SE (2012) Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol 60:1067\u20131076","journal-title":"J Am Coll Cardiol"},{"key":"1513_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/ejechocard\/jer289","volume":"13","author":"F Cappelli","year":"2012","unstructured":"Cappelli F, Porciani MC, Bergesio F, Perlini S, Attan\u00e0 P, Moggi Pignone A, Salinaro F, Musca F, Padeletti L, Perfetto F (2012) Right ventricular function in AL amyloidosis: characteristics and prognostic implication. Eur Heart J Cardiovasc Imaging 13:416\u2013422","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1513_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/13506129.2014.884971","volume":"21","author":"F Cappelli","year":"2014","unstructured":"Cappelli F, Baldasseroni S, Bergesio F, Padeletti L, Attan\u00e0 P, Pignone AM, Grifoni E, Ciuti G, Fabbri A, Tarantini F, Marchionni N, Gensini GF, Perfetto F (2014) Biohumoral markers as predictor of right ventricular dysfunction in AL amyloidosis. Amyloid 21:97\u2013102","journal-title":"Amyloid"},{"key":"1513_CR25","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ejheart.2007.05.006","volume":"9","author":"S Ghio","year":"2007","unstructured":"Ghio S, Perlini S, Palladini G, Marsan NA, Faggiano G, Vezzoli M, Klersy C, Campana C, Merlini G, Tavazzi L (2007) Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis. Eur J Heart Fail 9:808\u2013813","journal-title":"Eur J Heart Fail"},{"key":"1513_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2141.2007.06659.x","volume":"138","author":"O Enrico","year":"2007","unstructured":"Enrico O, Gabriele B, Nadia C, Sara G, Daniele V, Giulia C, Antonio S, Mario P (2007) Unexpected cardiotoxicity in haematological bortezomib treated patients. Br J Haematol 138:396\u2013397","journal-title":"Br J Haematol"},{"key":"1513_CR27","doi-asserted-by":"publisher","first-page":"28982","DOI":"10.3402\/jchimp.v5.28982","volume":"5","author":"MG Maseeha","year":"2015","unstructured":"Maseeha MG, Kolade VO, Attia MN (2015) Partially reversible bortezomib-induced cardiotoxicity: an unusual cause of acute cardiomyopathy. J Community Hosp Intern Med Perspect 5:28982","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"1513_CR28","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00277-014-2026-z","volume":"93","author":"A Subedi","year":"2014","unstructured":"Subedi A, Sharma LR, Shah BK (2014) Bortezomib-induced acute congestive heart failure: a case report and review of literature. Ann Hematol 93:1797\u20131799","journal-title":"Ann Hematol"},{"key":"1513_CR29","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.4081\/hr.2013.e12","volume":"5","author":"S Yamasaki","year":"2013","unstructured":"Yamasaki S, Muta T, Higo T, Kusumoto H, Zaitsu E, Miyamoto T, Oda Y, Akashi K (2013) Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis. Hematol Rep 5:e12","journal-title":"Hematol Rep"},{"key":"1513_CR30","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.4081\/hr.2016.6417","volume":"8","author":"N Jaipaul","year":"2016","unstructured":"Jaipaul N, Pi A, Zhang Z (2016) Recurrent syncope and cardiac arrest in a patient with systemic light chain amyloidosis treated with bortezomib. Hematol Rep 8:6417","journal-title":"Hematol Rep"},{"key":"1513_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/bjh.14708","volume":"178","author":"JP Laubach","year":"2017","unstructured":"Laubach JP, Moslehi JJ, Francis SA, San Miguel JF, Sonneveld P, Orlowski RZ, Moreau P, Rosi\u00f1ol L, Faber EA Jr, Voorhees P, Mateos MV, Marquez L, Feng H, Desai A, van de Velde H, Elliott J, Shi H, Dow E, Jobanputra N, Esseltine DL, Niculescu L, Anderson KC, Lonial S, Richardson PG (2017) A retrospective analysis of 3954 patients in phase 2\/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma. Br J Haematol 178:547\u2013560","journal-title":"Br J Haematol"},{"key":"1513_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ejca.2017.02.004","volume":"76","author":"F Le Bras","year":"2017","unstructured":"Le Bras F, Molinier-Frenkel V, Guellich A, Dupuis J, Belhadj K, Guendouz S, Ayad K, Colombat M, Benhaiem N, Tissot CM, Hulin A, Jaccard A, Damy T (2017) Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis. Eur J Cancer 76:183\u2013187","journal-title":"Eur J Cancer"},{"key":"1513_CR33","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0002-9149(02)02886-2","volume":"90","author":"GT Lau","year":"2002","unstructured":"Lau GT, Tan HC, Kritharides L (2002) Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 90:1405\u20131409","journal-title":"Am J Cardiol"},{"key":"1513_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00380-017-1043-y","volume":"33","author":"K Wan","year":"2018","unstructured":"Wan K, Sun J, Han Y, Luo Y, Liu H, Yang D, Cheng W, Zhang Q, Zeng Z, Chen Y (2018) Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis. Heart Vessels 33:170\u2013179","journal-title":"Heart Vessels"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-019-01513-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T23:30:04Z","timestamp":1600990204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-019-01513-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1007\/s00380-019-01513-y","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"assertion":[{"value":"7 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}